We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




NIH Awards USD 1.6 Million Grant to Subtle Medical

By MedImaging International staff writers
Posted on 03 Oct 2019
The National Institutes of Health {(NIH) Bethesda, MA, USA} has awarded healthcare technology company Subtle Medical (Menlo Park, CA, USA) a Fast-Track Small Business Innovation Research (SBIR) grant of USD 1.6 million. The 2.5-year fast track to Phase 2 award will fund an artificial intelligence (AI) product, SubtleGAD, in development by Subtle Medical aimed at reducing gadolinium dosage needed during MRI exams using deep learning (DL). The work will lead to safer contrast-enhanced MRI.

Over 40 million MRI scans are performed annually. Gadolinium-based contrast agents (GBCAs) are used in approximately one-third of all MRI scans. The usage of GBCAs has been linked to the development of nephrogenic systemic fibrosis (NSF). NSF can be painful, cause severe disability, and even death. The recent identification of gadolinium deposition within the brain and body has raised additional safety concerns about the usage of GBCAs. The FDA recently issued warnings about gadolinium retention following contrast-enhanced MRI and required GBCA manufacturers to conduct human and animal studies to further assess the safety of these contrast agents.

Subtle Medical, a healthcare technology company out of Stanford University, has developed a suite of deep learning solutions that enable centers to increase medical imaging speed, improve patient experience and reduce cost. Subtle's first product, SubtlePET, is the first FDA-cleared and CE-marked AI solution for medical imaging enhancement, enabling centers to enhance images from up to 4x faster PET scans. Subtle's second product, SubtleMR, currently under FDA review, was developed with the aim of faster MRI exams. SubtleGAD is the third product under development in Subtle Medical's growing portfolio of new AI technologies. The low-dose contrast-enhanced MRI method will benefit not only millions of patients with advanced chronic kidney disease (CKD) who cannot currently undergo contrast-enhanced MRI, but many more patients with normal kidney function, who are at the risk of gadolinium retention after a contrast-enhanced MRI.

"With SubtleGAD technology, hospitals and imaging centers will be able to deliver safer MRI exams without sacrificing the clinical quality of the images," said Enhao Gong, PhD, Co-founder & CEO of Subtle Medical. "We are grateful to receive NIH's support to further the development of our AI product and bring it into clinical use."

Related Links:
National Institutes of Health
Subtle Medical

Ultrasound Needle Guidance System
SonoSite L25
New
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Biopsy Software
Affirm® Contrast
Ultrasonic Pocket Doppler
SD1

Channels

Nuclear Medicine

view channel
Image: The diagnostic tool could improve diagnosis and treatment decisions for patients with chronic lung infections (Photo courtesy of SNMMI)

Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections

Mycobacteroides abscessus is a rapidly growing mycobacteria that primarily affects immunocompromised patients and those with underlying lung diseases, such as cystic fibrosis or chronic obstructive pulmonary... Read more

General/Advanced Imaging

view channel
Image: Dynamic CT enables earlier and more accurate screening of patients who require uterine artery embolization (Photo courtesy of Yamaguchi et al.)

New CT-Based Indicator Helps Predict Life-Threatening Postpartum Bleeding Cases

Postpartum hemorrhage (PPH) is a leading cause of maternal death worldwide. While most cases can be controlled with medications and basic interventions, some become life-threatening and require invasive treatments.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.